NCI, CDC, FDA,
and ASPE will continue to collaborate on design, content, and
analysis of the CPS-TUS survey, consistent with the memorandum that
is included in this information collection request (see
supplemental documents).
Inventory as of this Action
Requested
Previously Approved
06/30/2016
24 Months From Approved
127,500
0
0
12,750
0
0
0
0
0
The 2014-15 Tobacco Use
Supplement-Current Population Survey (TUS-CPS) will be conducted by
the Census Bureau and is co-sponsored by the National Cancer
Institute (NCI) and the Food and Drug Administration (FDA). Fielded
since 1992, most recently in 2010-11, this survey is part of a
continuing series of surveys (OMB No. 0925-0368) sponsored by NCI
that has been administered triennially as part of the Census
Bureau's and the Bureau of Labor Statistics' CPS. For the TUS-CPS,
data will be collected from the U.S. civilian non-institutionalized
population on smoking, other tobacco use, including switching,
flavors, dependence, cessation attempts, and policy and social
norms. The TUS-CPS has been a key source of national, state, some
local-level, and health disparity data on these topics in U.S.
households because it uses a large, nationally representative
sample. The 2014-15 TUS-CPS is designed to meet both NCI's and
FDA's goals. The NCI and FDA are co-sponsoring the 2014-15 TUS-CPS
through parallel, but separate interagency agreements with the
Census Bureau. The NCI is particularly focused on policy
information such as home and workplace smoking policies, cigarette
price, and impact of these on subsequent purchase and use behavior;
and changes in smoking norms and attitudes. The FDA aims to support
research to aid the development and evaluation of tobacco product
regulations. The research findings generated from this program are
expected to provide data to inform FDA regulation of the
manufacture, distribution, and marketing of tobacco products to
protect public health. A unique feature is the ability to link
other social and economic Census Bureau and Bureau of Labor
Statistics data, other sponsor-supported supplement data, and the
National Longitudinal Mortality Study cancer incidence and
cause-specific mortality data to the TUS-CPS data. Data will be
collected in July 2014, January 2015, and May 2015 from about
255,000 respondents.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.